STAGE IIIC BREAST CANCER
Clinical trials for STAGE IIIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough breast cancer: drug combo shows promise in trial
Disease control CompletedThis study tested a drug called alisertib, either alone or combined with fulvestrant, in 96 postmenopausal women with advanced breast cancer that had stopped responding to hormone therapy. The goal was to see if these treatments could shrink tumors. Alisertib works by blocking en…
Matched conditions: STAGE IIIC BREAST CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
New drug combo offers hope for elderly breast cancer patients avoiding surgery
Disease control CompletedThis study tested a combination of two drugs, fulvestrant and palbociclib, in older patients with hormone-sensitive breast cancer who either couldn't have surgery or chose not to. The goal was to see if the treatment could control the cancer for at least a year without needing su…
Matched conditions: STAGE IIIC BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Can fish oil and arthritis drugs fight pregnancy breast cancer?
Knowledge-focused CompletedThis study looked at whether two anti-inflammatory drugs—fish oil and celecoxib (an arthritis medication)—can reduce inflammation and slow cancer spread in women with pregnancy-associated breast cancer. 42 women aged 18-50 with various stages of breast cancer took the drugs for a…
Matched conditions: STAGE IIIC BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC